Product Information
MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.4579 per EA under NDC 68682011320. Its NADAC has been published 294 times since Feb 19, 2020.
Strength
375 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682011320
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
MESALAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022301On Market Since
7/19/2018
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 294 times since Feb 19, 2020, and over the history we have for it it has declined 84.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4579 per EA |
|---|---|
| All-time high | $3.1530 (Aug 12, 2020) |
| All-time low | $0.4468 (Jul 17, 2024) |
| 52-week high | $0.4912 |
| 52-week low | $0.4579 |
| Median price | $0.9990 |
| Average price | $1.3864 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 294 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by Oceanside Pharmaceuticals, is $0.4579 per EA (NDC 68682011320), effective Oct 1, 2025.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 84.5%. It has been tracked across 294 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Feb 19, 2020, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4468 (Jul 17, 2024) to a high of $3.1530 (Aug 12, 2020), with a median of $0.9990 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE ER 0.375 GRAM CAP, but none are currently priced below it.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 68682011320) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification